Fighting Cancer With Genetic Modification: CRISPR Approved For First Human Trial

The Recombinant DNA Advisory Committee (RAC) at the U.S. National Institutes of Health has just given the nod for the first human trials of CRISPR-edited gene therapy.

June 25, 2016
Subscribe
Like us on Facebook